Latest filing published 15 Jun 2023 for Vaxcyte, Inc..
Insider track record
No signal scores available.
Michael E. Kamarck: trading record in brief
Filings by Michael E. Kamarck span 2 companies, the busiest being Wyeth and Vaxcyte, Inc. Over a trading history stretching from 27 February 2009 to 13 June 2023, the count stands at 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 15 June 2023 came the latest disclosure, a share grant in Vaxcyte, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael E. Kamarck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares0Common StockSEC:0001209191-23-037504:0
- 3,125 shares0Common StockSEC:0001209191-22-034067:0
- 30,495 sharesCommon StockSEC:0001209191-09-049093:0
- 1,195 shares@ US$42.10Common StockSEC:0001209191-09-023207:0
- 7,072 shares0Common StockSEC:0001209191-09-013480:0
- 2,165 shares@ US$41.14Common StockSEC:0001209191-09-013480:1
6 of 6 declarations
